These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 30526279)

  • 1. Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease.
    La EM; Talbird SE; Kanadanian KV; Huang L; Fain J; Srivastava A
    Hum Vaccin Immunother; 2019; 15(4):978-986. PubMed ID: 30526279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.
    Soeters HM; Whaley M; Alexander-Scott N; Kanadanian KV; MacNeil JR; Martin SW; McNamara LA; Sicard K; Vanner C; Vuong J; Wang X; Bandy U; Patel M;
    Clin Infect Dis; 2017 Apr; 64(8):1115-1122. PubMed ID: 28158417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons from mass vaccination response to meningococcal B outbreaks at US universities.
    Alderfer J; Isturiz RE; Srivastava A
    Postgrad Med; 2020 Sep; 132(7):614-623. PubMed ID: 32476532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak.
    Capitano B; Dillon K; LeDuc A; Atkinson B; Burman C
    Hum Vaccin Immunother; 2019; 15(3):717-724. PubMed ID: 30462563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB-FHbp.
    Burman C; Alderfer J; Snow VT
    J Clin Pharm Ther; 2020 Apr; 45(2):270-281. PubMed ID: 31820483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.
    Marjuki H; Chang HY; Topaz N; Whaley MJ; Vuong J; Chen A; Jenkins LT; Hu F; Schmink S; Retchless AC; Thomas JD; Acosta AM; McNamara LA; Soeters HM; Mbaeyi S; Wang X
    mBio; 2021 May; 12(3):. PubMed ID: 34006659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.
    Beeslaar J; Absalon J; Balmer P; Srivastava A; Maansson R; York LJ; Perez JL
    Vaccine; 2018 Jun; 36(28):4004-4013. PubMed ID: 29861182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).
    Gandhi A; Balmer P; York LJ
    Postgrad Med; 2016 Aug; 128(6):548-56. PubMed ID: 27467048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015-2016.
    McNamara LA; Thomas JD; MacNeil J; Chang HY; Day M; Fisher E; Martin S; Poissant T; Schmink SE; Steward-Clark E; Jenkins LT; Wang X; Acosta A;
    J Infect Dis; 2017 Nov; 216(9):1130-1140. PubMed ID: 28968661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Mass Vaccination Clinics in Response to a Serogroup B Meningococcal Disease Outbreak at a Large, Public University-Oregon, 2015.
    Fisher EA; Poissant T; Luedtke P; Leman R; Young C; Cieslak P
    J Adolesc Health; 2018 Aug; 63(2):151-156. PubMed ID: 30149923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.
    Soeters HM; McNamara LA; Blain AE; Whaley M; MacNeil JR; Hariri S; Mbaeyi SA;
    Emerg Infect Dis; 2019 Mar; 25(3):434-440. PubMed ID: 30789140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents.
    Vesikari T; Østergaard L; Beeslaar J; Absalon J; Eiden JJ; Jansen KU; Jones TR; Harris SL; Maansson R; Munson S; O'Neill RE; York LJ; Perez JL
    Vaccine; 2019 Mar; 37(12):1710-1719. PubMed ID: 30770221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological impact and cost-effectiveness of universal meningitis b vaccination among college students prior to college entry.
    Chung GS; Hutton DW
    PLoS One; 2020; 15(10):e0239926. PubMed ID: 33035260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada
    Langley JM; Gantt S; Quach C; Bettinger JA; Halperin SA; Mutch J; McNeil SA; Ward BJ; MacKinnon-Cameron D; Ye L; Marty K; Scheifele D; Brown E; Alcantara J;
    Emerg Infect Dis; 2020 Mar; 26(3):454-462. PubMed ID: 32091358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid response to a college outbreak of meningococcal serogroup B disease: Nation's first widespread use of bivalent rLP2086 vaccine.
    Fiorito TM; Bornschein S; Mihalakos A; Kelleher CM; Alexander-Scott N; Kanadanian KV; Raymond P; Sicard K; Dennehy PH
    J Am Coll Health; 2017; 65(4):294-296. PubMed ID: 28121236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France.
    Taha MK; Hawkins JC; Liberator P; Deghmane AE; Andrew L; Hao L; Jones TR; McNeil LK; O'Neill RE; Perez JL; Jansen KU; Anderson AS
    Vaccine; 2017 Mar; 35(11):1530-1537. PubMed ID: 28196734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal serogroup B outbreak response University of Wisconsin-Madison.
    Ritscher AM; Ranum N; Malak JD; Ahrabi-Fard S; Baird J; Berti AD; Curtis W; Holden M; Jones CD; Kind J; Kinsey W; Koepke R; Schauer SL; Stein E; Van Orman S; Ward BG; Zahner SJ; Hayney MS
    J Am Coll Health; 2019 Apr; 67(3):191-196. PubMed ID: 29952729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serogroup B Meningococcal Disease Outbreak and Carriage Evaluation at a College - Rhode Island, 2015.
    Soeters HM; McNamara LA; Whaley M; Wang X; Alexander-Scott N; Kanadanian KV; Kelleher CM; MacNeil J; Martin SW; Raines N; Sears S; Vanner C; Vuong J; Bandy U; Sicard K; Patel M;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):606-7. PubMed ID: 26068563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US College Students Are at Increased Risk for Serogroup B Meningococcal Disease.
    Marshall GS; Dempsey AF; Srivastava A; Isturiz RE
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):244-247. PubMed ID: 31077326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine.
    Lujan E; Partridge E; Giuntini S; Ram S; Granoff DM
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.